Literature DB >> 29507154

Narrowing the treatment gap in managing opioid use disorder.

Joseph H Donroe1, Jeanette M Tetrault2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29507154      PMCID： PMC5837871          DOI： 10.1503/cmaj.180209

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

Review 1.  Caring for patients with opioid use disorder in the hospital.

Authors:  Joseph H Donroe; Stephen R Holt; Jeanette M Tetrault
Journal:  CMAJ       Date:  2016-09-19       Impact factor: 8.262

2.  Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study.

Authors:  Julie Dupouy; Aurore Palmaro; Mélina Fatséas; Marc Auriacombe; Joëlle Micallef; Stéphane Oustric; Maryse Lapeyre-Mestre
Journal:  Ann Fam Med       Date:  2017-07       Impact factor: 5.166

3.  Treatment utilization among persons with opioid use disorder in the United States.

Authors:  Li-Tzy Wu; He Zhu; Marvin S Swartz
Journal:  Drug Alcohol Depend       Date:  2016-10-19       Impact factor: 4.492

4.  Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.

Authors:  Gregory M Lucas; Amina Chaudhry; Jeffrey Hsu; Tanita Woodson; Bryan Lau; Yngvild Olsen; Jeanne C Keruly; David A Fiellin; Ruth Finkelstein; Patricia Barditch-Crovo; Katie Cook; Richard D Moore
Journal:  Ann Intern Med       Date:  2010-06-01       Impact factor: 25.391

5.  The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.

Authors:  James E Egan; Paul Casadonte; Tracy Gartenmann; Judith Martin; Elinore F McCance-Katz; Julie Netherland; John A Renner; Linda Weiss; Andrew J Saxon; David A Fiellin
Journal:  J Gen Intern Med       Date:  2010-05-11       Impact factor: 5.128

6.  Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.

Authors:  Joshua D Lee; Edward V Nunes; Patricia Novo; Ken Bachrach; Genie L Bailey; Snehal Bhatt; Sarah Farkas; Marc Fishman; Phoebe Gauthier; Candace C Hodgkins; Jacquie King; Robert Lindblad; David Liu; Abigail G Matthews; Jeanine May; K Michelle Peavy; Stephen Ross; Dagmar Salazar; Paul Schkolnik; Dikla Shmueli-Blumberg; Don Stablein; Geetha Subramaniam; John Rotrosen
Journal:  Lancet       Date:  2017-11-14       Impact factor: 79.321

Review 7.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 8.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

9.  American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.

Authors:  Kyle Kampman; Margaret Jarvis
Journal:  J Addict Med       Date:  2015 Sep-Oct       Impact factor: 3.702

10.  Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders.

Authors:  Miriam Komaromy; Dan Duhigg; Adam Metcalf; Cristina Carlson; Summers Kalishman; Leslie Hayes; Tom Burke; Karla Thornton; Sanjeev Arora
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716
  10 in total
  1 in total

Review 1.  Identification and Management of Opioid Use Disorder in Primary Care: an Update.

Authors:  Joseph H Donroe; Elenore P Bhatraju; Judith I Tsui; E Jennifer Edelman
Journal:  Curr Psychiatry Rep       Date:  2020-04-13       Impact factor: 5.285
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.